Association of TGF-β1 polymorphisms with chronic renal disease

Journal of Nephrology

Volumn 17, Issue 6, 2004, Pages 794-799

  Coll, Elisabeth ^a   Cormand, Bru ^a   Campos, Begoña ^a   González Núñez, Daniel ^a   Iñigo, Pablo ^b   Botey, Albert ^a   Poch, Esteban ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Cardiovascular disease; Fibrosis; Genetics; Polymorphism; Renal disease; Transforming growth factor

Indexed keywords

ARGININE; LEUCINE; PROLINE; TRANSFORMING GROWTH FACTOR BETA1; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ALLELE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CODON; COHORT ANALYSIS; CONTROLLED STUDY; DIALYSIS; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; KIDNEY FAILURE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; RISK FACTOR; CHRONIC DISEASE; CHRONIC KIDNEY FAILURE; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ARGININE; CHRONIC DISEASE; CODON; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; KIDNEY FAILURE, CHRONIC; LEUCINE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROLINE; RETROSPECTIVE STUDIES; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 16644373416     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Klahr S, Schreiner G, Ichikawa I. The progression of renal disease. N Engl J Med 1988; 318: 1657-66.
2. Zoccali C. Cardiovascular risk in uraemic patients: is it fully explained by classical risk factors? Nephrol Dial Transplant 2000; 15: 454-7.
3. Anderson S, Meyer TW, Rennke HG, Brenner BM. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 1985; 76: 612-9.
4. Remuzzi G, Ruggenenti P, Perico N. Chronic renal diseases: Renoprotective benefits of renin-angiotensin system inhibition. Ann Intern Med 2002; 136: 604-15.
5. Marx M, Sterzel RB, Sorokin L. Renal matrix and adhesion in injury and inflammation. Curr Opin Nephrol Hypertens 1993; 2: 527-35.
6. Border WA, Noble NA. Transforming growth factor-β in tissue fibrosis. N Engl J Med 1994; 331: 1286-92.
7. Villarreal FJ, Dillmann WH. Cardiac hypertrophy-induced changes in mRNA levels of TGF, fibronectin, and collagen. Am J Physiol 1992; 262: H1861-6.
8. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J Clin Invest 1993; 92: 2597-601.
9. Yamamoto T, Noble NA, Cohen AH, Nast CC, Hishida A, Gold LI, Border WA. Expression of TGF-beta isoforms in human glomerular diseases. Kidney Int 1996; 49: 461-9.
10. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-β1 gene. Transplantation 1998; 66: 1014-20.
11. Cambien F, Ricard S, Troesch A, Mallet C, Generenaz L, Evans A, Arveiler D, Luc G, Ruidavets JB, Poirier O. Polymorphisms of the transforming growth factor-β1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de L'Infarctus du Myocarde (ECTIM study). Hypertension 1996; 28: 881-7.
12. Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, Carter ND, Spector TD. Genetic control of the circulating concentration of transforming growth factor type β1. Hum Mol Genet 1999; 8: 93-7.
13. El-Gamel A, Awad M, Sim E, Hasleton P, Yonan N, Egan J, Diraniya A, Hutchinson IV. Transforming growth factor-β1 and lung allograft fibrosis. Eur J Cardiothorac Surg 1998; 13: 424-30.
14. Li B, Khanna A, Sharma V, Singh T, Suthanthiran M, August P. TGF-β1 DNA polymorphisms, protein levels, and blood pressure. Hypertension 1999; 33: 271-5.
15. Pociot F, Hansen PM, Karlsen AE, Langdahl BL, Johannesen J, Nerup J. TGF-beta1 gene mutations in insulin-dependent diabetes mellitus and diabetic nephropathy. J Am Soc Nephrol 1998; 9: 2302-7.
16. Lario S, Iñgo P, Campistol JM, Poch E, Rivera F, Oppenheimer F. Restriction enzyme-based method for transforming growth factor-β1 genotyping: nonisotopic detection of polymorphisms in codons 10 and 25 and the 5′-flanking region. Clin Chem 1999; 45: 1290-2.
17. Terwilliger J, Ott T. Handbook of human genetic linkage. Baltimore: John Hopkins University Press 1994.
18. Stephens M, Smith N, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-89.
19. Dickson K, Philip A, Warshawsky H, O'Connor-McCourt M, Bergeron JJ. Specific binding of endocrine transforming growth factor-β1 to vascular endothelium. J Clin Invest 1995; 95: 2539-54.
20. Zeiher AM, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991; 83: 391-401.
21. Grainger DJ, Kemp PR, Metcalfe JC, Liu AC, Lawn RM, Williams NR, Grace AA, Schofield PM, Chauhan A. The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis. Nat Med 1995; 1: 74-9.
22. Agrotis A, Saltis J, Bobik A. Transforming growth factor-β1 gene activation and growth of smooth muscle from hypertensive rats. Hypertension 1994; 23: 593-9.
23. Ohno M, Cooke JP, Dzau VJ, Gibbons GH. Fluid shear stress induces endothelial TGF-β1 transcription and production: modulation by potassium channel blockade. J Clin Invest 1995; 95: 1363-9.
24. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH. Transforming growth factor β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A 1986; 83: 4167-71.
25. Takahashi N, Calderone A, Izzo NJ Jr, Maki TM, Marsh JD, Colucci WS. Hypertrophic stimuli induce transforming growth factor-β1 expression in rat ventricular myocytes. J Clin Invest 1994; 94: 1470-6.
26. Yokota M, Ichihara S, Lin TL, Nakashima N, Yamada Y. Association of a T29 →C polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 2000; 101: 2783-7.
27. Akai Y, Sato H, Ozaki H, Iwano M, Dohi Y, Kanauchi M. Association of transforming growth factor-beta1 T29C polymorphism with the progression of diabetic nephropathy. Am J Kidney Dis 2001; 38 (suppl 1): S182-5.
28. Brezzi B, Brugnara M, Lupo A, Magistroni R, Furci L, Ligabue G, Bernich P, Turco A, Gomez-Lira M, Del Prete D, Maschio G. Genetic polymorphisms of TGF-beta1 and histological damage in IgA nephropathy. J Am Soc Nephrol 2002; 13: 131A.
29. Brezzi B, Lupo A, Brugnara M, Ligabue G, Magistroni R, Marcantoni C, Gomez-Lira M, Gambaro G, Turco A, Poli A, Maschio G. TGF-beta1 COD10 polymorphism is associated with progressive IgA nephropathy. J Am Soc Nephrol 2002; 13: 130A.
30. Colhoun HM, McKeigue PM, Smith GD. Problems of reporting genetic associations with complex outcomes. Lancet 2003; 361: 865-72.